+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Protein Assays Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 195 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968902
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The protein assays market is in a pivotal phase, driven by evolving diagnostic needs, ongoing innovation in assay technologies, and shifting supply chain strategies. Senior decision-makers require timely, practical intelligence to steer strategy and investment within this rapidly adapting sector.

Market Snapshot: Protein Assays Market Performance

The protein assays market advanced from USD 3.36 billion in 2024 to USD 3.80 billion in 2025, reflecting robust momentum and signaling a continued upward trend at a compound annual growth rate (CAGR) of 13.19%. Industry projections anticipate the market will reach USD 9.06 billion by 2032. This impressive expansion is driven by the introduction of innovative assay platforms, growing usage across life sciences and diagnostics, and organizational shifts aligned with the latest regulatory and tariff policies. As demand diversifies, organizations are refining strategies to strengthen market presence, supported by a resilient and responsive industry ecosystem.

Scope & Segmentation

  • Product Types: Assay kits and reagents for multiple detection methods; instruments including microplate readers and mass spectrometry systems; and comprehensive service offerings such as contract research, consulting, maintenance, technical support, and training for process optimization.
  • Technologies: Enzyme-linked immunosorbent assay (ELISA) formats, advanced liquid chromatography mass spectrometry platforms—including Orbitrap, time-of-flight, triple quadrupole—plus surface plasmon resonance (SPR), and Western blotting, enabling expanded use and sensitivity across applications.
  • End Users: Academic and research institutes; contract research organizations; hospitals and clinical diagnostic laboratories; and pharmaceutical and biotechnology companies, spanning both established players and emerging entities within the sector.
  • Applications: Disease research and diagnostics for genetic, infectious, and oncology-related applications; drug discovery and development activities; environmental monitoring; and analysis in the food and beverage industry, addressing diverse global requirements.
  • Geographies: Regional analysis covers the Americas, including the United States, Canada, and Latin America; Europe, the Middle East and Africa with notable Western European and emerging African markets; and Asia-Pacific regions, focusing on China, India, and important Southeast Asian economies.
  • Leading Companies: Profiles include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Bio-Rad Laboratories, Roche Holding AG, Agilent Technologies, PerkinElmer, Bio-Techne Corporation, Promega Corporation, and Abcam plc, showcasing innovation leadership and dynamic competitive strategies.

Key Takeaways: Strategic Insights for Senior Leadership

  • Continuous platform innovation is improving assay precision and expanding utilization from academic research through clinical diagnostics, supporting broader end-user engagement and enhanced operational outcomes.
  • Integrated service models—combining contract research, specialized support, and expert consulting—are central to maximizing returns on instrumentation and optimizing workflow efficiencies across multiple stakeholder groups.
  • Preference is shifting toward modular, platform-independent systems, offering providers scalable and flexible solutions that adapt readily to workflow adjustments and changing regulatory landscapes.
  • Strategic market approaches must be tailored to local infrastructure readiness, the availability of skilled personnel, and the evolving regulatory environment across key regions.
  • Collaboration between manufacturers, contract research organizations, and research institutes accelerates validation and adoption of novel protein assay technologies, strengthening overall market responsiveness.

Tariff Impact on Supply Chains and Cost Structures

Recent U.S. tariffs targeting imported reagents, instruments, and components have led organizations to adjust procurement and logistics frameworks. Companies are increasingly focused on domestic sourcing and supplier diversification to balance cost pressures. These measures have encouraged a greater emphasis on local innovation in reagent development and expanded local service agreements. Although short-term challenges may impact operations, agile realignment across procurement supports long-term supply chain resilience and secures continuity in development activities for key market participants.

Methodology & Data Sources

This analysis uses a transparent, multi-source approach. Insights from interviews with senior leaders in research institutions, diagnostics labs, contract research organizations, and pharmaceutical manufacturers form the foundation. Findings are corroborated by in-depth reviews of scientific literature, regulatory filings, and the latest patent data. Triangulation of sources ensures objective and reliable results for stakeholders in the protein assays market.

Why This Report Matters: Decision Enablement for Senior Stakeholders

  • Delivers a segmented overview, enabling leadership to inform strategy, optimize investments, and benchmark operational best practices in the protein assays market.
  • Identifies key growth, compliance, and risk management opportunities within changing technological and regulatory contexts, supporting confident decision-making for senior stakeholders.
  • Assists organizations in benchmarking competitor strategies and innovation roadmaps for potential business development or mergers and acquisitions activities.

Conclusion

The protein assays market is transforming, shaped by technological progression, regulation, and evolving supply chain priorities. This intelligence supports leadership in navigating market shifts, managing risk, and capturing growth opportunities with assurance.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Rapid adoption of digital ELISA platforms for ultrasensitive protein biomarker quantification
5.2. Integration of microfluidic lab-on-a-chip systems for high throughput protein interaction screening
5.3. Emergence of label-free surface plasmon resonance assays for real-time kinetic protein analysis
5.4. Application of single-cell proteomics technologies for heterogeneity profiling in disease research
5.5. Growing utilization of multiplex immunoassays for simultaneous detection of multiple cytokines
5.6. Increased demand for rapid point-of-care protein assays in decentralized clinical settings
5.7. Incorporation of artificial intelligence and machine learning in assay optimization and data interpretation
5.8. Adoption of sustainable green chemistry reagents in protein assay protocols to reduce environmental impact
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Protein Assays Market, by Product Type
8.1. Assay Kits & Reagents
8.1.1. Lateral Flow
8.1.2. Microplate Based
8.2. Instruments
8.2.1. Lc Ms Systems
8.2.2. Microplate Readers
8.2.3. Spr Systems
8.3. Services
8.3.1. Contract Research
8.3.2. Maintenance & Consulting
8.3.3. Training & Support
9. Protein Assays Market, by Technology
9.1. Enzyme Linked Immunosorbent Assay
9.2. Liquid Chromatography Mass Spectrometry
9.2.1. Orbitrap
9.2.2. Time Of Flight
9.2.3. Triple Quadrupole
9.3. Surface Plasmon Resonance
9.4. Western Blotting
10. Protein Assays Market, by End User
10.1. Academic And Research Institutes
10.2. Contract Research Organizations
10.3. Hospitals And Diagnostic Laboratories
10.4. Pharmaceutical And Biotechnology Companies
10.4.1. Large Pharmaceutical
10.4.2. Small And Medium Pharmaceutical
11. Protein Assays Market, by Application
11.1. Disease Research And Diagnostics
11.1.1. Genetic Disorders
11.1.2. Infectious Diseases
11.1.3. Oncology
11.2. Drug Discovery And Development
11.3. Environmental Testing
11.4. Food And Beverage Analysis
12. Protein Assays Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Protein Assays Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Protein Assays Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Merck KGaA
15.3.3. Danaher Corporation
15.3.4. Bio-Rad Laboratories, Inc.
15.3.5. Roche Holding AG
15.3.6. Agilent Technologies, Inc.
15.3.7. PerkinElmer, Inc.
15.3.8. Bio-Techne Corporation
15.3.9. Promega Corporation
15.3.10. Abcam plc
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Protein Assays market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Roche Holding AG
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Bio-Techne Corporation
  • Promega Corporation
  • Abcam plc

Table Information